1. Adams RN, Athinarayanan SJ, McKenzie AL, Hallberg SJ, McCarter JP, Phinney SD, Gonzalez JS. Depressive symptoms improve over 2 years of type 2 diabetes treatment via a digital continuous remote care intervention focused on carbohydrate restriction. J Behav Med 2022; 45: 416–427.
2.
Anderson J, Ozan E, Chouinard VA, Grant G, MacDonald A, Thakkar L, Palmer C. The Ketogenic Diet as a Transdiagnostic Treatment for Neuropsychiatric Disorders: Mechanisms and Clinical Outcomes. Curr Treat Options Psychiatry 2024; 12: 1.
3.
Brandt J, Buchholz A, Henry-Barron B, Vizthum D, Avramopoulos D, Cervenka MC. Preliminary Report on the Feasibility and Efficacy of the Modified Atkins Diet for Treatment of Mild Cognitive Impairment and Early Alzheimer’s Disease. J Alzheimers Dis JAD 2019; 68: 969–981.
4.
Brenton JN, Lehner-Gulotta D, Woolbright E, Banwell B, Bergqvist AGC, Chen S, Coleman R, Conaway M, Goldman MD. Phase II study of ketogenic diets in relapsing multiple sclerosis: safety, tolerability and potential clinical benefits. J Neurol Neurosurg Psychiatry 2022; 93: 637–644.
5.
Calabrese L, Scolnic B, Zupec-Kania B, Beckwith C, Costello K, Frank GKW. Ketogenic diet and ketamine infusion treatment to target chronic persistent eating disorder psychopathology in anorexia nervosa: a pilot study. Eat Weight Disord - Stud Anorex Bulim Obes 2022; 27: 3751–3757.
6.
Campbell IH, Campbell H. Ketosis and bipolar disorder: controlled analytic study of online reports. BJPsych Open 2019; 5: e58.
7.
Carmen M, Safer DL, Saslow LR, Kalayjian T, Mason AE, Westman EC, Sethi S. Treating binge eating and food addiction symptoms with low-carbohydrate Ketogenic diets: a case series. J Eat Disord 2020; 8: 2.
8.
Chmiel I. Ketogenic diet in therapy of bipolar affective disorder – case report and literature review. Psychiatr Pol 2022; 56: 1345–1363.
9.
Chmiel I, Łojko D. Nutripsychiatria – interwencje żywieniowe w zaburzeniach afektywnych i lękowych. PZWL PWN, Warszawa 2024.
10.
Crosby L, Davis B, Joshi S, Jardine M, Paul J, Neola M, Barnard ND. Ketogenic Diets and Chronic Disease: Weighing the Benefits Against the Risks. Front Nutr 2021; 8: 702802.
11.
Croteau, E., Castellano, CA, Fortier M, Bocti C, Fulop T, Paquet N, Cunnane SC. A cross-sectional comparison of brain glucose and ketone metabolism in cognitively healthy older adults, mild cognitive impairment and early Alzheimer’s disease. Exp Gerontol 2018; 107: 18–26.
12.
Danan A, Westman EC, Saslow LR, Ede G. The Ketogenic Diet for Refractory Mental Illness: A Retrospective Analysis of 31 Inpatients. Front Psychiatry 2022; 13: 951376.
13.
Dietch DM, Kerr-Gaffney J, Hockey M, Marx W, Ruusunen A, Young AH, Berk M, Mondelli V. Efficacy of low carbohydrate and ketogenic diets in treating mood and anxiety disorders: systematic review and implications for clinical practice. BJPsych Open 2023; 9: e70.
14.
Dowis K, Banga S. The Potential Health Benefits of the Ketogenic Diet: A Narrative Review. Nutrients 2021; 13: 1654.
15.
Dyńka D, Rodzeń Ł, Rodzeń M, Pacholak-Klimas A, Ede G, et al.. Ketogenic Diets for Body Weight Loss: A Comparison with Other Diets. Nutrients 2025; 17: 965.
16.
Ede G. Change your diet, change your mind. Yellow Kite, London 2024.
17.
Field R, Field T, Pourkazemi F, Rooney K.. Ketogenic diets and the nervous system: a scoping review of neurological outcomes from nutritional ketosis in animal studies. Nutr Res Rev 2022; 35: 268–281.
18.
Gilbert-Jaramillo J, Vargas-Pico D, Espinosa-Mendoza T, Falk S, Llanos-Fernandez K, Guerrero-Haro J, Orellana-Roman C, Poveda-Loor C, Valdevila-Figueira J, Palmer C. The effects of the ketogenic diet on psychiatric symptomatology, weight and metabolic dysfunction in schizophrenia patients. Clin Nutr Metab 2018.1. https://doi.org/10.15761/CNM.1000105.
19.
Grammatikopoulou MG, Goulis DG, Gkiouras K, Theodoridis X, Gkouskou KK, Evangeliou A, Dardiotis E, Bogdanos DP. To Keto or Not to Keto? A Systematic Review of Randomized Controlled Trials Assessing the Effects of Ketogenic Therapy on Alzheimer Disease. Adv Nutr Bethesda Md 2020; 11: 1583–1602.
20.
Höhn S, Dozières-Puyravel B, Auvin S. History of dietary treatment from Wilder’s hypothesis to the first open studies in the 1920s. Epilepsy Behav 2019; 101: 106588.
21.
IJff DM, Postulart D, Lambrechts DAJE, Majoie MHJM, De Kinderen RJA, Hendriksen JGM, et al. Cognitive and behavioral impact of the ketogenic diet in children and adolescents with refractory epilepsy: A randomized controlled trial. Epilepsy Behav 2016; 60: 153–157.
22.
Ji J, Fotros D, Sohouli MH, Velu P, Fatahi S, Liu Y. The effect of a ketogenic diet on inflammation-related markers: a systematic review and meta-analysis of randomized controlled trials. Nutr Rev 2025; 83: 40–58.
23.
Kackley ML, Brownlow ML, Buga A, Crabtree CD, Sapper TN, O’Connor A, Volek JS. The effects of a 6-week controlled, hypocaloric ketogenic diet, with and without exogenous ketone salts, on cognitive performance and mood states in overweight and obese adults. Front Neurosci 2022; 16: 971144.
24.
Karimzadeh P, Tabrizi A. A Journey of Dietary Therapies for Epilepsy in Iran: Diet Restriction in the Ancient Era to the Ketogenic Diet in the Modern Period. Iran J Child Neurol 2019; 13: 7–24.
25.
Kolb H, Kempf K, Röhling M, Lenzen-Schulte M, Schloot NC, Martin S. Ketone bodies: from enemy to friend and guardian angel. BMC Med. 2021; 19: 313.
26.
Kossoff EH, Dorward JL. The Modified Atkins Diet. Epilepsia 2008; 49: 37–41.
27.
Kossoff EH, Zupec‐Kania BA, Amark PE, Ballaban‐Gil KR, Christina Bergqvist AG, Blackford R, et al. The Charlie Foundation, and the Practice Committee of the Child Neurology Society, 2009. Optimal clinical management of children receiving the ketogenic diet: Recommendations of the International Ketogenic Diet Study Group. Epilepsia 2009; 50: 304–317. https://doi.org/10.1111/j.1528-1167.2008.01765.x.
28.
Lai KSP, Liu CS, Rau A, Lanctôt KL, Köhler CA, Pakosh M, Carvalho AF, Herrmann N. Peripheral inflammatory markers in Alzheimer’s disease: a systematic review and meta-analysis of 175 studies. J Neurol Neurosurg Psychiatry 2017; 88: 876–882.
29.
Laurent N. Retrospective case study: ketogenic metabolic therapy in the effective management of treatment-resistant depressive symptoms in bipolar disorder. Front Nutr 2024; 11: 1394679.
30.
Laurent N, Bellamy EL, Hristova D, Houston A. Ketogenic diets in clinical psychology: examining the evidence and implications for practice. Front Psychol 2024; 15: 1468894.
31.
Luscher B, Shen Q, Sahir N. The GABAergic deficit hypothesis of major depressive disorder. Mol Psychiatry 2011; 16: 383–406.
32.
Łojko D, Rybakowski J. Metabolic psychiatry – a new concept of etiopathogenesis and treatment of mental disorders. Neuropsychiatr Neuropsychol 2024; 19: 83–89.
33.
Martin-McGill KJ, Bresnahan R, Levy RG, Cooper PN. Ketogenic diets for drug-resistant epilepsy. Cochrane Database Syst. Rev. 2020. https://doi.org/10.1002/14651858.CD001903.pub5.
34.
McClernon FJ, Yancy WS, Eberstein JA, Atkins RC, Westman EC. The Effects of a Low‐Carbohydrate Ketogenic Diet and a Low‐Fat Diet on Mood, Hunger, and Other Self‐Reported Symptoms. Obesity 2007; 15: 182–182.
35.
McDonald TJW, Cervenka MC. Ketogenic Diets for Adult Neurological Disorders. Neurotherapeutics 2018; 15: 1018–1031.
36.
McGrath T, Baskerville R, Rogero M, Castell L. Emerging Evidence for the Widespread Role of Glutamatergic Dysfunction in Neuropsychiatric Diseases. Nutrients 2022, 14 (5): 917.
37.
Mentzelou M, Dakanalis A, Vasios GK, Gialeli M, Papadopoulou SK, Giaginis C. The Relationship of Ketogenic Diet with Neurodegenerative and Psychiatric Diseases: A Scoping Review from Basic Research to Clinical Practice. Nutrients 2023; 15: 2270.
38.
Mhanna A, Mhanna M, Beran A, Al-Chalabi M, Aladamat N, Mahfooz N. Modified Atkins diet versus ketogenic diet in children with drug-resistant epilepsy: A meta-analysis of comparative studies. Clin Nutr ESPEN 2022; 51: 112–119.
39.
Möhler H. The GABA system in anxiety and depression and its therapeutic potential. Neuropharmacology 2012; 62: 42–53.
40.
Monzel AS, Enríquez JA, Picard M. Multifaceted mitochondria: moving mitochondrial science beyond function and dysfunction. Nat Metab 2023; 5: 546–562.
41.
Neal EG, Chaffe H, Schwartz RH, Lawson MS, Edwards N, Fitzsimmons G, Whitney A, Cross JH. A randomized trial of classical and medium‐chain triglyceride ketogenic diets in the treatment of childhood epilepsy. Epilepsia 2009; 50: 1109–1117.
42.
Needham N, Campbell IH, Grossi H, Kamenska I, Rigby BP, Simpson SA et al. Pilot study of a ketogenic diet in bipolar disorder. BJPsych Open 2023; 9: e176.
43.
Norwitz NG, Hurn M, Espi Forcen F. Animal-based ketogenic diet puts severe anorexia nervosa into multi-year remission: A case series. J Metab Health 2023; 6.
44.
Pacheco A, Easterling WS, Pryer MW. A pilot study of the ketogenic diet in schizophrenia. Am J Psychiatry 1965; 121: 1110–1111.
45.
Pallotto M, Deprez F. Regulation of adult neurogenesis by GABAergic transmission: signaling beyond GABAA-receptors. Front Cell Neurosci 2014; 8. https://doi.org/10.3389/fncel.2014.00166.
46.
Palmer C. Brain Energy. BenBelaBooks, Dallas 2022.
47.
Palmer CM. Ketogenic diet in the treatment of schizoaffective disorder: Two case studies. Schizophr Res 2017; 189: 208–209.
48.
Palmer CM, Gilbert-Jaramillo J, Westman EC. The ketogenic diet and remission of psychotic symptoms in schizophrenia: Two case studies. Schizophr Rev 2019; 208: 439–440.
49.
Paoli A, Cerullo G. Investigating the Link between Ketogenic Diet, NAFLD, Mitochondria, and Oxidative Stress: A Narrative Review. Antioxidants 2023; 12: 1065.
50.
Paoli A, Mancin L, Bianco A, Thomas E, Mota JF, Piccini F. Ketogenic Diet and Microbiota: Friends or Enemies? Genes 2019; 10: 534.
51.
Phelps JR, Siemers SV, El-Mallakh RS. The ketogenic diet for type II bipolar disorder. Neurocase 2013; 19: 423–426.
52.
Phillips MCL, Deprez LM, Mortimer GMN, Murtagh DKJ, McCoy S, Mylchreest R et al. Randomized crossover trial of a modified ketogenic diet in Alzheimer’s disease. Alzheimers Res Ther 2021; 13: 51. https://doi.org/10.1186/s13195-021-00783-x
53.
Pietrzak D, Kasperek K, Rękawek P, Piątkowska-Chmiel I. The Therapeutic Role of Ketogenic Diet in Neurological Disorders. Nutrients 2022; 14: 1952.
54.
Puchalska P, Crawford PA. Metabolic and Signaling Roles of Ketone Bodies in Health and Disease. Annu Rev Nutr 2021; 41: 49–77.
55.
Rezaei S, Abdurahman AA, Saghazadeh A, Badv RS, Mahmoudi M. Short-term and long-term efficacy of classical ketogenic diet and modified Atkins diet in children and adolescents with epilepsy: A systematic review and meta-analysis. Nutr Neurosci 2019; 22: 317–334.
56.
Sampaio LPDB. Ketogenic diet for epilepsy treatment. Arq Neuropsiquiatr 2016; 74: 842–848.
57.
Saraga M, Misson N, Cattani E. Ketogenic diet in bipolar disorder. Bipolar Disord 2020; 22: 765.
58.
Scaini G, Andrews T, Lima CNC, Benevenuto D, Streck EL, Quevedo J. Mitochondrial dysfunction as a critical event in the pathophysiology of bipolar disorder. Mitochondrion 2021; 57: 23–36.
59.
Schwartz RH, Eaton J, Bower BD, Aynsley‐Green A. Ketogenic diets in the treatment of epilepsy: short term clinical effects. Dev Med Child Neurol 1989; 31: 145–151.
60.
Seethalakshmi R, Parkar S, Nair N, Adarkar S, Pandit A, Batra S et al. Regional brain metabolism in schizophrenia: An FDG-PET study. Indian J Psychiatry 2006; 48: 149.
61.
Sethi S, Berk M, Andreazza AC, Mujica-Parodi LR, Campbell I, Campbell H et al. Metabolic Psychiatry: A Conceptual Framework Targeting Metabolic Dysfunction in Psychiatric Disease 2024 a; https://doi.org/10.31234/osf.io/wm8g3.
62.
Sethi S, Wakeham D, Ketter T, Hooshmand F, Bjornstad J, Richards B et al. Ketogenic Diet Intervention on Metabolic and Psychiatric Health in Bipolar and Schizophrenia: A Pilot Trial. Psychiatry Res 2024 b; 335: 115866.
63.
Sethi S, Ford J. The Role of Ketogenic Metabolic Therapy on the Brain in Serious Mental Illness: A Review. J Psychiatry Brain Sci 2022; 7 (5): e220009.
64.
Sharma S, Jain P. The Modified Atkins Diet in Refractory Epilepsy. Epilepsy Res Treat 2014; 2014: 404202.
65.
Shegelman A, Carson KA, McDonald TJW, Henry-Barron BJ, Diaz-Arias LA, Cervenka MC. The psychiatric effects of ketogenic diet therapy on adults with chronic epilepsy. Epilepsy Behav 2021; 117: 107807.
66.
Song Y, Cao H, Zuo C, Gu Z, Huang Y, Miao J, Fu Y, Guo Y, Jiang Y, Wang F. Mitochondrial dysfunction: A fatal blow in depression. Biomed Pharmacother. 2023; 167: 115652.
67.
Steardo L, Fabrazzo M, Sampogna G, Monteleone AM, D’Agostino G, Monteleone P, Maj M. Impaired glucose metabolism in bipolar patients and response to mood stabilizer treatments. J Affect Disord. 2019; 245: 174–179.
68.
Su L, Cai Y, Xu Y, Dutt A, Shi S, Bramon E. Cerebral metabolism in major depressive disorder: a voxel-based meta-analysis of positron emission tomography studies. BMC Psychiatry 2014; 14: 321.
69.
Taylor MK, Sullivan DK, Mahnken JD, Burns JM, Swerdlow RH. Feasibility and efficacy data from a ketogenic diet intervention in Alzheimer’s disease. Alzheimers Dement N Y 2017; 4: 28–36.
70.
Teicholz N, Croft SM, Cuaranta I, Cucuzzella M, Glandt M, Griauzde DH et al. Myths and Facts Regarding Low-Carbohydrate Diets. Nutrients 2025; 17 (6): 1047.
71.
Varaee H, Darand M, Hassanizadeh S, Hosseinzadeh M. Effect of low-carbohydrate diet on depression and anxiety: A systematic review and meta-analysis of controlled trials. J Affect Disord 2023; 325: 206–214.
72.
Vidali S, Aminzadeh S, Lambert B, Rutherford T, Sperl W, Kofler, B. et al. Mitochondria: The ketogenic diet – A metabolism-based therapy. Int J Biochem Cell Biol 2015; 63: 55–59.
73.
Wheless JW. History of the ketogenic diet. Epilepsia 2008; 49: 3–5.
74.
Wiers CE, Manza P, Wang GJ, Volkow ND. Ketogenic diet reduces a neurobiological craving signature in alcohol use disorder. Front Nutr 2024 Feb 12; 11: 1254341.
75.
Wiers CE, Vendruscolo LF, Van Der Veen JW, Manza P, Shokri-Kojori E, Kroll DS et al. Ketogenic diet reduces alcohol withdrawal symptoms in humans and alcohol intake in rodents. Sci Adv. 2021; 7: eabf6780.
76.
Yousufzai W, Singh M, Ahmadi L, Balamurali S, Bavishi D, Ashraf S et al. Measuring the effects of ketogenic diet on neuropsychiatric disorder: A scoping review. Prog Neuropsychopharmacol Biol Psychiatry 2025; 136: 111205.
77.
Yuan N, Chen Y, Xia Y, Dai J, Liu C. Inflammation-related biomarkers in major psychiatric disorders: a cross-disorder assessment of reproducibility and specificity in 43 meta-analyses. Transl Psychiatry 2019; 9: 233.
78.
Yudkoff M, Daikhin Y, Horyn O, Nissim Ilana, Nissim Itzhak. Ketosis and brain handling of glutamate, glutamine, and GABA. Epilepsia 2008; 49: 73–75.
